Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 22 |
NetGPI | no | yes: 0, no: 22 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005929 | cilium | 4 | 23 |
GO:0042995 | cell projection | 2 | 23 |
GO:0043226 | organelle | 2 | 23 |
GO:0043227 | membrane-bounded organelle | 3 | 23 |
GO:0110165 | cellular anatomical entity | 1 | 23 |
GO:0120025 | plasma membrane bounded cell projection | 3 | 23 |
GO:0005743 | mitochondrial inner membrane | 5 | 1 |
GO:0016020 | membrane | 2 | 2 |
GO:0019866 | organelle inner membrane | 4 | 1 |
GO:0031090 | organelle membrane | 3 | 1 |
GO:0031966 | mitochondrial membrane | 4 | 1 |
GO:0005737 | cytoplasm | 2 | 1 |
Related structures:
AlphaFold database: Q4QJ80
Term | Name | Level | Count |
---|---|---|---|
GO:0006950 | response to stress | 2 | 1 |
GO:0006952 | defense response | 3 | 1 |
GO:0050896 | response to stimulus | 1 | 1 |
GO:0006793 | phosphorus metabolic process | 3 | 2 |
GO:0006796 | phosphate-containing compound metabolic process | 4 | 2 |
GO:0008152 | metabolic process | 1 | 2 |
GO:0009987 | cellular process | 1 | 3 |
GO:0016310 | phosphorylation | 5 | 2 |
GO:0044237 | cellular metabolic process | 2 | 2 |
GO:0006468 | protein phosphorylation | 5 | 1 |
GO:0006807 | nitrogen compound metabolic process | 2 | 1 |
GO:0019538 | protein metabolic process | 3 | 1 |
GO:0036211 | protein modification process | 4 | 1 |
GO:0043170 | macromolecule metabolic process | 3 | 1 |
GO:0043412 | macromolecule modification | 4 | 1 |
GO:0044238 | primary metabolic process | 2 | 1 |
GO:0071704 | organic substance metabolic process | 2 | 1 |
GO:1901564 | organonitrogen compound metabolic process | 3 | 1 |
GO:0000226 | microtubule cytoskeleton organization | 3 | 1 |
GO:0006457 | protein folding | 2 | 1 |
GO:0006996 | organelle organization | 4 | 1 |
GO:0007010 | cytoskeleton organization | 5 | 1 |
GO:0007017 | microtubule-based process | 2 | 1 |
GO:0007021 | tubulin complex assembly | 6 | 1 |
GO:0007023 | post-chaperonin tubulin folding pathway | 3 | 1 |
GO:0016043 | cellular component organization | 3 | 1 |
GO:0022607 | cellular component assembly | 4 | 1 |
GO:0043933 | protein-containing complex organization | 4 | 1 |
GO:0065003 | protein-containing complex assembly | 5 | 1 |
GO:0071840 | cellular component organization or biogenesis | 2 | 1 |
Term | Name | Level | Count |
---|---|---|---|
GO:0003824 | catalytic activity | 1 | 6 |
GO:0016787 | hydrolase activity | 2 | 4 |
GO:0005488 | binding | 1 | 3 |
GO:0043167 | ion binding | 2 | 2 |
GO:0043169 | cation binding | 3 | 1 |
GO:0046872 | metal ion binding | 4 | 1 |
GO:0016301 | kinase activity | 4 | 2 |
GO:0016740 | transferase activity | 2 | 2 |
GO:0016772 | transferase activity, transferring phosphorus-containing groups | 3 | 2 |
GO:0000166 | nucleotide binding | 3 | 1 |
GO:0004672 | protein kinase activity | 3 | 1 |
GO:0005524 | ATP binding | 5 | 1 |
GO:0016773 | phosphotransferase activity, alcohol group as acceptor | 4 | 1 |
GO:0017076 | purine nucleotide binding | 4 | 1 |
GO:0030554 | adenyl nucleotide binding | 5 | 1 |
GO:0032553 | ribonucleotide binding | 3 | 1 |
GO:0032555 | purine ribonucleotide binding | 4 | 1 |
GO:0032559 | adenyl ribonucleotide binding | 5 | 1 |
GO:0035639 | purine ribonucleoside triphosphate binding | 4 | 1 |
GO:0036094 | small molecule binding | 2 | 1 |
GO:0043168 | anion binding | 3 | 1 |
GO:0097159 | organic cyclic compound binding | 2 | 1 |
GO:0097367 | carbohydrate derivative binding | 2 | 1 |
GO:0140096 | catalytic activity, acting on a protein | 2 | 1 |
GO:1901265 | nucleoside phosphate binding | 3 | 1 |
GO:1901363 | heterocyclic compound binding | 2 | 1 |
GO:0005515 | protein binding | 2 | 1 |
GO:0008092 | cytoskeletal protein binding | 3 | 1 |
GO:0015631 | tubulin binding | 4 | 1 |
GO:0043014 | alpha-tubulin binding | 5 | 1 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_C14_Caspase3-7 | 204 | 208 | PF00656 | 0.657 |
CLV_C14_Caspase3-7 | 247 | 251 | PF00656 | 0.264 |
CLV_C14_Caspase3-7 | 58 | 62 | PF00656 | 0.587 |
CLV_NRD_NRD_1 | 124 | 126 | PF00675 | 0.597 |
CLV_NRD_NRD_1 | 558 | 560 | PF00675 | 0.529 |
CLV_PCSK_KEX2_1 | 124 | 126 | PF00082 | 0.534 |
CLV_PCSK_KEX2_1 | 558 | 560 | PF00082 | 0.530 |
CLV_PCSK_SKI1_1 | 124 | 128 | PF00082 | 0.558 |
CLV_PCSK_SKI1_1 | 276 | 280 | PF00082 | 0.467 |
CLV_PCSK_SKI1_1 | 346 | 350 | PF00082 | 0.498 |
DOC_CDC14_PxL_1 | 230 | 238 | PF14671 | 0.356 |
DOC_CDC14_PxL_1 | 413 | 421 | PF14671 | 0.497 |
DOC_CDC14_PxL_1 | 482 | 490 | PF14671 | 0.257 |
DOC_CYCLIN_RxL_1 | 172 | 181 | PF00134 | 0.453 |
DOC_CYCLIN_RxL_1 | 276 | 289 | PF00134 | 0.250 |
DOC_CYCLIN_RxL_1 | 417 | 428 | PF00134 | 0.497 |
DOC_CYCLIN_yClb5_NLxxxL_5 | 303 | 312 | PF00134 | 0.250 |
DOC_MAPK_gen_1 | 124 | 131 | PF00069 | 0.464 |
DOC_MAPK_gen_1 | 237 | 246 | PF00069 | 0.262 |
DOC_MAPK_gen_1 | 253 | 263 | PF00069 | 0.503 |
DOC_MAPK_gen_1 | 276 | 286 | PF00069 | 0.250 |
DOC_MAPK_gen_1 | 343 | 353 | PF00069 | 0.466 |
DOC_MAPK_gen_1 | 35 | 43 | PF00069 | 0.633 |
DOC_MAPK_MEF2A_6 | 124 | 133 | PF00069 | 0.453 |
DOC_MAPK_MEF2A_6 | 66 | 73 | PF00069 | 0.671 |
DOC_MAPK_NFAT4_5 | 124 | 132 | PF00069 | 0.341 |
DOC_MIT_MIM_1 | 121 | 129 | PF04212 | 0.348 |
DOC_PP2B_LxvP_1 | 95 | 98 | PF13499 | 0.478 |
DOC_PP4_FxxP_1 | 219 | 222 | PF00568 | 0.320 |
DOC_USP7_MATH_1 | 418 | 422 | PF00917 | 0.518 |
DOC_USP7_MATH_1 | 50 | 54 | PF00917 | 0.424 |
DOC_USP7_UBL2_3 | 100 | 104 | PF12436 | 0.401 |
DOC_WW_Pin1_4 | 405 | 410 | PF00397 | 0.502 |
DOC_WW_Pin1_4 | 476 | 481 | PF00397 | 0.401 |
DOC_WW_Pin1_4 | 522 | 527 | PF00397 | 0.546 |
LIG_14-3-3_CanoR_1 | 154 | 162 | PF00244 | 0.442 |
LIG_14-3-3_CanoR_1 | 184 | 190 | PF00244 | 0.443 |
LIG_14-3-3_CanoR_1 | 243 | 252 | PF00244 | 0.412 |
LIG_14-3-3_CanoR_1 | 313 | 318 | PF00244 | 0.441 |
LIG_14-3-3_CanoR_1 | 452 | 459 | PF00244 | 0.473 |
LIG_14-3-3_CanoR_1 | 528 | 537 | PF00244 | 0.402 |
LIG_14-3-3_CanoR_1 | 66 | 72 | PF00244 | 0.621 |
LIG_Actin_WH2_2 | 335 | 351 | PF00022 | 0.300 |
LIG_Actin_WH2_2 | 498 | 514 | PF00022 | 0.441 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.414 |
LIG_BIR_III_2 | 169 | 173 | PF00653 | 0.352 |
LIG_BIR_III_2 | 415 | 419 | PF00653 | 0.398 |
LIG_BIR_III_2 | 46 | 50 | PF00653 | 0.421 |
LIG_DLG_GKlike_1 | 245 | 252 | PF00625 | 0.313 |
LIG_DLG_GKlike_1 | 313 | 320 | PF00625 | 0.250 |
LIG_FHA_1 | 163 | 169 | PF00498 | 0.516 |
LIG_FHA_1 | 6 | 12 | PF00498 | 0.660 |
LIG_FHA_1 | 68 | 74 | PF00498 | 0.623 |
LIG_FHA_2 | 116 | 122 | PF00498 | 0.429 |
LIG_FHA_2 | 299 | 305 | PF00498 | 0.406 |
LIG_FHA_2 | 332 | 338 | PF00498 | 0.526 |
LIG_FHA_2 | 370 | 376 | PF00498 | 0.362 |
LIG_FHA_2 | 377 | 383 | PF00498 | 0.411 |
LIG_LIR_Apic_2 | 217 | 222 | PF02991 | 0.307 |
LIG_LIR_Apic_2 | 406 | 410 | PF02991 | 0.340 |
LIG_LIR_Gen_1 | 375 | 384 | PF02991 | 0.532 |
LIG_LIR_Nem_3 | 375 | 381 | PF02991 | 0.528 |
LIG_LIR_Nem_3 | 46 | 51 | PF02991 | 0.643 |
LIG_LYPXL_yS_3 | 48 | 51 | PF13949 | 0.421 |
LIG_SH2_CRK | 407 | 411 | PF00017 | 0.346 |
LIG_SH2_STAP1 | 24 | 28 | PF00017 | 0.384 |
LIG_SH2_STAT5 | 283 | 286 | PF00017 | 0.431 |
LIG_SH2_STAT5 | 403 | 406 | PF00017 | 0.463 |
LIG_SH2_STAT5 | 79 | 82 | PF00017 | 0.528 |
LIG_SH3_3 | 109 | 115 | PF00018 | 0.517 |
LIG_SUMO_SIM_anti_2 | 38 | 46 | PF11976 | 0.344 |
LIG_SUMO_SIM_anti_2 | 454 | 463 | PF11976 | 0.530 |
LIG_SUMO_SIM_anti_2 | 500 | 507 | PF11976 | 0.552 |
LIG_SUMO_SIM_par_1 | 130 | 136 | PF11976 | 0.310 |
LIG_SUMO_SIM_par_1 | 212 | 217 | PF11976 | 0.464 |
LIG_SUMO_SIM_par_1 | 512 | 517 | PF11976 | 0.372 |
LIG_TRAF2_1 | 199 | 202 | PF00917 | 0.667 |
LIG_TRAF2_1 | 487 | 490 | PF00917 | 0.322 |
LIG_TYR_ITIM | 281 | 286 | PF00017 | 0.411 |
LIG_WW_3 | 438 | 442 | PF00397 | 0.333 |
MOD_CDC14_SPxK_1 | 525 | 528 | PF00782 | 0.365 |
MOD_CDK_SPxK_1 | 522 | 528 | PF00069 | 0.368 |
MOD_CK1_1 | 17 | 23 | PF00069 | 0.513 |
MOD_CK1_1 | 196 | 202 | PF00069 | 0.592 |
MOD_CK1_1 | 298 | 304 | PF00069 | 0.350 |
MOD_CK1_1 | 316 | 322 | PF00069 | 0.215 |
MOD_CK1_1 | 369 | 375 | PF00069 | 0.423 |
MOD_CK1_1 | 425 | 431 | PF00069 | 0.397 |
MOD_CK1_1 | 454 | 460 | PF00069 | 0.364 |
MOD_CK1_1 | 474 | 480 | PF00069 | 0.354 |
MOD_CK1_1 | 500 | 506 | PF00069 | 0.454 |
MOD_CK1_1 | 520 | 526 | PF00069 | 0.516 |
MOD_CK1_1 | 67 | 73 | PF00069 | 0.422 |
MOD_CK2_1 | 196 | 202 | PF00069 | 0.599 |
MOD_CK2_1 | 298 | 304 | PF00069 | 0.401 |
MOD_CK2_1 | 331 | 337 | PF00069 | 0.482 |
MOD_CK2_1 | 388 | 394 | PF00069 | 0.517 |
MOD_CK2_1 | 428 | 434 | PF00069 | 0.511 |
MOD_CK2_1 | 529 | 535 | PF00069 | 0.497 |
MOD_DYRK1A_RPxSP_1 | 522 | 526 | PF00069 | 0.368 |
MOD_GlcNHglycan | 202 | 206 | PF01048 | 0.656 |
MOD_GlcNHglycan | 230 | 233 | PF01048 | 0.536 |
MOD_GlcNHglycan | 3 | 6 | PF01048 | 0.683 |
MOD_GlcNHglycan | 308 | 311 | PF01048 | 0.378 |
MOD_GlcNHglycan | 352 | 356 | PF01048 | 0.401 |
MOD_GlcNHglycan | 38 | 41 | PF01048 | 0.602 |
MOD_GlcNHglycan | 390 | 393 | PF01048 | 0.393 |
MOD_GlcNHglycan | 506 | 509 | PF01048 | 0.530 |
MOD_GlcNHglycan | 52 | 55 | PF01048 | 0.596 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.663 |
MOD_GSK3_1 | 196 | 203 | PF00069 | 0.659 |
MOD_GSK3_1 | 331 | 338 | PF00069 | 0.422 |
MOD_GSK3_1 | 388 | 395 | PF00069 | 0.473 |
MOD_GSK3_1 | 418 | 425 | PF00069 | 0.401 |
MOD_GSK3_1 | 454 | 461 | PF00069 | 0.507 |
MOD_GSK3_1 | 470 | 477 | PF00069 | 0.362 |
MOD_GSK3_1 | 500 | 507 | PF00069 | 0.397 |
MOD_GSK3_1 | 516 | 523 | PF00069 | 0.348 |
MOD_GSK3_1 | 562 | 569 | PF00069 | 0.611 |
MOD_N-GLC_1 | 14 | 19 | PF02516 | 0.411 |
MOD_N-GLC_1 | 306 | 311 | PF02516 | 0.349 |
MOD_N-GLC_1 | 425 | 430 | PF02516 | 0.519 |
MOD_N-GLC_1 | 471 | 476 | PF02516 | 0.375 |
MOD_N-GLC_1 | 517 | 522 | PF02516 | 0.573 |
MOD_N-GLC_2 | 448 | 450 | PF02516 | 0.475 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.655 |
MOD_NEK2_1 | 162 | 167 | PF00069 | 0.453 |
MOD_NEK2_1 | 200 | 205 | PF00069 | 0.658 |
MOD_NEK2_1 | 214 | 219 | PF00069 | 0.421 |
MOD_NEK2_1 | 284 | 289 | PF00069 | 0.374 |
MOD_NEK2_1 | 329 | 334 | PF00069 | 0.312 |
MOD_NEK2_1 | 36 | 41 | PF00069 | 0.519 |
MOD_NEK2_1 | 376 | 381 | PF00069 | 0.360 |
MOD_NEK2_1 | 422 | 427 | PF00069 | 0.391 |
MOD_NEK2_1 | 459 | 464 | PF00069 | 0.345 |
MOD_NEK2_1 | 470 | 475 | PF00069 | 0.264 |
MOD_NEK2_1 | 516 | 521 | PF00069 | 0.386 |
MOD_NEK2_1 | 551 | 556 | PF00069 | 0.662 |
MOD_NEK2_1 | 562 | 567 | PF00069 | 0.474 |
MOD_NEK2_1 | 64 | 69 | PF00069 | 0.630 |
MOD_NEK2_2 | 106 | 111 | PF00069 | 0.405 |
MOD_NEK2_2 | 392 | 397 | PF00069 | 0.472 |
MOD_NEK2_2 | 471 | 476 | PF00069 | 0.256 |
MOD_OFUCOSY | 63 | 68 | PF10250 | 0.413 |
MOD_PIKK_1 | 193 | 199 | PF00454 | 0.450 |
MOD_PIKK_1 | 295 | 301 | PF00454 | 0.370 |
MOD_PIKK_1 | 366 | 372 | PF00454 | 0.480 |
MOD_PKA_2 | 153 | 159 | PF00069 | 0.518 |
MOD_PKA_2 | 183 | 189 | PF00069 | 0.458 |
MOD_PKA_2 | 244 | 250 | PF00069 | 0.488 |
MOD_PKA_2 | 451 | 457 | PF00069 | 0.520 |
MOD_PKB_1 | 243 | 251 | PF00069 | 0.267 |
MOD_Plk_1 | 374 | 380 | PF00069 | 0.421 |
MOD_Plk_1 | 382 | 388 | PF00069 | 0.434 |
MOD_Plk_1 | 425 | 431 | PF00069 | 0.416 |
MOD_Plk_1 | 454 | 460 | PF00069 | 0.298 |
MOD_Plk_1 | 471 | 477 | PF00069 | 0.257 |
MOD_Plk_1 | 500 | 506 | PF00069 | 0.489 |
MOD_Plk_1 | 516 | 522 | PF00069 | 0.488 |
MOD_Plk_1 | 540 | 546 | PF00069 | 0.663 |
MOD_Plk_1 | 64 | 70 | PF00069 | 0.614 |
MOD_Plk_4 | 214 | 220 | PF00069 | 0.496 |
MOD_Plk_4 | 335 | 341 | PF00069 | 0.385 |
MOD_ProDKin_1 | 405 | 411 | PF00069 | 0.510 |
MOD_ProDKin_1 | 476 | 482 | PF00069 | 0.406 |
MOD_ProDKin_1 | 522 | 528 | PF00069 | 0.552 |
TRG_DiLeu_BaEn_1 | 158 | 163 | PF01217 | 0.487 |
TRG_DiLeu_BaLyEn_6 | 477 | 482 | PF01217 | 0.261 |
TRG_DiLeu_LyEn_5 | 147 | 152 | PF01217 | 0.334 |
TRG_ENDOCYTIC_2 | 283 | 286 | PF00928 | 0.431 |
TRG_ENDOCYTIC_2 | 390 | 393 | PF00928 | 0.325 |
TRG_ENDOCYTIC_2 | 48 | 51 | PF00928 | 0.594 |
TRG_ER_diArg_1 | 123 | 125 | PF00400 | 0.595 |
TRG_ER_diArg_1 | 243 | 246 | PF00400 | 0.272 |
TRG_ER_diArg_1 | 312 | 315 | PF00400 | 0.333 |
TRG_ER_diArg_1 | 396 | 399 | PF00400 | 0.500 |
TRG_ER_diArg_1 | 510 | 513 | PF00400 | 0.532 |
TRG_Pf-PMV_PEXEL_1 | 125 | 130 | PF00026 | 0.449 |
TRG_Pf-PMV_PEXEL_1 | 402 | 406 | PF00026 | 0.463 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P8N9 | Leptomonas seymouri | 27% | 87% |
A0A0N1P921 | Leptomonas seymouri | 27% | 70% |
A0A0S4JC97 | Bodo saltans | 24% | 68% |
A0A0S4JR29 | Bodo saltans | 25% | 100% |
A0A1X0NEN5 | Trypanosomatidae | 23% | 98% |
A0A1X0P4M6 | Trypanosomatidae | 26% | 98% |
A0A3Q8IAE2 | Leishmania donovani | 81% | 91% |
A0A3Q8IGD6 | Leishmania donovani | 24% | 71% |
A0A3S5ISR4 | Trypanosoma rangeli | 26% | 68% |
A0A3S7X2V4 | Leishmania donovani | 28% | 74% |
A4H3R1 | Leishmania braziliensis | 27% | 83% |
A4HCY0 | Leishmania braziliensis | 26% | 100% |
A4I6T8 | Leishmania infantum | 24% | 71% |
C9ZK22 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 26% | 70% |
C9ZS86 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 25% | 100% |
E9AGT5 | Leishmania infantum | 81% | 100% |
E9AHJ6 | Leishmania infantum | 28% | 74% |
E9AIU4 | Leishmania braziliensis | 26% | 100% |
Q4Q6A2 | Leishmania major | 25% | 71% |
Q4QD45 | Leishmania major | 100% | 100% |
V5BKI3 | Trypanosoma cruzi | 27% | 69% |